Purpose
to support early evaluation of a novel technology that could be used with polio VLP-based vaccines to induce mucosal immunity, providing a non-infectious polio vaccine that would protect against transmission in the countries at highest risk
Grantee
Division
Global Development
Date
SEPTEMBER 2024
Region served
GLOBAL
Committed amount
$546,018
Grant topic
Polio
Duration (months)
10
Grantee location
Israel
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.